UNKNOWNNA

Application of 3D Printing in Laparoscopic Surgery of Liver Tumors

To explore the utility of personalized 3D printed liver models in planning and navigating laparoscopic resections.

Sponsor

Jagiellonian University

Enrollment

85 participants

Sites

1 locations

Start Date

April 2017

Completion

June 2022

Liver CancerHepatocellular CarcinomaLiver MetastasesLaparoscopic liver resection3D printing model

Enrollment & Timeline

UNKNOWN

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

5.7 years

total trial span

Rate

pts/month needed

Apr 2017Month 108 of 68Jun 2022

100% of trial timeline elapsed

At 1 sites, each site needs to enroll approximately 1.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Number of changes in surgery plan

intraoperative

Blood loss

intraoperative

Operative time

intraoperative

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Cost-effective, personalized, 3D-printed liver model for preoperative planning before laparoscopic liver hemihepatectomy for colorectal cancer metastases.

Witowski Jan Sylwester, Pędziwiatr Michał, Major Piotr et al.International journal of computer assisted radiology and surgery2018

DOI PubMed

Investigating accuracy of 3D printed liver models with computed tomography.

Witowski Jan, Wake Nicole, Grochowska Anna et al.Quantitative imaging in medicine and surgery2022

DOI PubMed

Decision-making based on 3D printed models in laparoscopic liver resections with intraoperative ultrasound: a prospective observational study.

Witowski Jan, Budzyński Andrzej, Grochowska Anna et al.European radiology2021

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

UNKNOWNNA

Application of 3D Printing in Laparoscopic Surgery of Liver Tumors

To explore the utility of personalized 3D printed liver models in planning and navigating laparoscopic resections.

Sponsor

Jagiellonian University

Enrollment

85 participants

Sites

1 locations

Start Date

April 2017

Completion

June 2022

Liver CancerHepatocellular CarcinomaLiver MetastasesLaparoscopic liver resection3D printing model

Enrollment & Timeline

UNKNOWN

Target enrollment (estimated)

Target N

participants

Sites

locations

Duration

5.7 years

total trial span

Rate

pts/month needed

Apr 2017Month 108 of 68Jun 2022

100% of trial timeline elapsed

At 1 sites, each site needs to enroll approximately 1.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Number of changes in surgery plan

intraoperative

Blood loss

intraoperative

Operative time

intraoperative

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Cost-effective, personalized, 3D-printed liver model for preoperative planning before laparoscopic liver hemihepatectomy for colorectal cancer metastases.

Witowski Jan Sylwester, Pędziwiatr Michał, Major Piotr et al.International journal of computer assisted radiology and surgery2018

DOI PubMed

Investigating accuracy of 3D printed liver models with computed tomography.

Witowski Jan, Wake Nicole, Grochowska Anna et al.Quantitative imaging in medicine and surgery2022

DOI PubMed

Decision-making based on 3D printed models in laparoscopic liver resections with intraoperative ultrasound: a prospective observational study.

Witowski Jan, Budzyński Andrzej, Grochowska Anna et al.European radiology2021

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Eligibility

Min Age

18 Years

Sex

all

Healthy Volunteers

View full criteria

Inclusion Criteria:

* Age over 18
* Patient qualified to undergo liver tumor resection (either primary of metastatic; both benign and malignant lesions)
* Quality of imaging (CT or MRI or PET (positron emission tomography)/CT) satisfactory to develop 3D models
* Laparoscopic approach
* Informed consent

Exclusion Criteria:

* Open approach
* Technical limitations to model development
* No informed consent

Application of 3D Printing in Laparoscopic Surgery of Liver Tumors

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Application of 3D Printing in Laparoscopic Surgery of Liver Tumors

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)